Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call
Friday, April 17, 2026 1 min read
Key Takeaway: Charles River Laboratories International, Inc. will release its first-quarter 2026 financial results on May 7th, prior to market opening. A conference call is set for the same day at 8:30 a.m. ET to discuss these results. Investors can access a live webcast and a replay through the company's Investor Relations website.
Price reaction · baseline $176.94 (2026-04-16 close) · hit pre-market · 1 other CRL headline(s) in the window, move may be shared
Conference call allows for direct communication with investors.
Charles River Laboratories continues to support drug development.
Full Press Release Details
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2026 financial results on Thursday, May 7th, before the market opens. A conference call has been scheduled to discuss this information on Thursday, May 7th, at 8:30 a.m. ET.
Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website atir.criver.com. A replay will be accessible through the same website.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visitwww.criver.com.